Literature DB >> 18854090

Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis.

Joseph Phillips1, Harry Staszewski, Michael Garrison.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is an overwhelming inflammatory response, associated with an outpouring of cytokines and inappropriate activation of the macrophage system, causing severe morbidity and possible death. HLH has inherited and acquired forms. Secondary HLH can be related to any number of underlying conditions including infections, malignancy and autoimmune diseases. There are similarities between "cytokine storm" seen in HLH and the clinical findings of avian influenza. We report a patient with a history of sarcoidosis on chronic steroid treatment, who developed HLH secondary to an infection with Histoplasma capsulatum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854090     DOI: 10.1179/102453308X316013

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  9 in total

1.  Disseminated Histoplasmosis with Haemophagocytic Lymphohistiocytosis in an Immunocompetent Host.

Authors:  Amey Dilip Sonavane; Pratibha Balasaheb Sonawane; Sachet Vijay Chandak; Pravin M Rathi
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 2.  Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.

Authors:  Steve Hu; Pranshu Bansal; David Lynch; Cristhiam Mauricio Rojas Hernandez; Zoneddy Dayao
Journal:  J Med Case Rep       Date:  2016-12-20

3.  Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.

Authors:  John Fredy Nieto-Rios; Sandra Milena Gómez de Los Ríos; Lina María Serna-Higuita; Catalina Ocampo-Kohn; Arbey Aristizabal-Alzate; Kenny Mauricio Gálvez-Cárdenas; Gustavo Adolfo Zuluaga-Valencia
Journal:  Colomb Med (Cali)       Date:  2016-12-30

4.  Hemophagocytic Lymphohistiocytosis Complicating Systemic Sarcoidosis.

Authors:  Omar Abughanimeh; Ayman Qasrawi; Mouhanna Abu Ghanimeh
Journal:  Cureus       Date:  2018-06-19

5.  Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in Rheumatologic Disease.

Authors:  Yael Kusne; Michael Christiansen; Christopher Conley; Juan Gea-Banacloche; Ayan Sen
Journal:  Case Rep Crit Care       Date:  2021-01-22

6.  Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.

Authors:  Jennifer Leigh Townsend; Satish Shanbhag; John Hancock; Kathryn Bowman; Ank E Nijhawan
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

7.  Hemophagocytic Lymphohistiocytosis Secondary to Human Immunodeficiency Virus-Associated Histoplasmosis.

Authors:  Anthony A Castelli; David G Rosenthal; Rachel Bender Ignacio; Helen Y Chu
Journal:  Open Forum Infect Dis       Date:  2015-09-19       Impact factor: 3.835

Review 8.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12

Review 9.  Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis: A Review of the Literature.

Authors:  Ra'ed Jabr; Wissam El Atrouni; Heather J Male; Kassem A Hammoud
Journal:  Can J Infect Dis Med Microbiol       Date:  2019-10-01       Impact factor: 2.471

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.